MyFinsight
Home
Compare
About
Recent SEC Filings
10/21
NETFLIX INC
(NFLX)
10/21
AT&T INC.
(T)
10/21
CSX CORP
(CSX)
10/21
United Airlines Holdings, Inc.
(UAL)
10/21
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
(WAB)
10/21
Elevance Health, Inc.
(ELV)
10/21
JOHNSON & JOHNSON
(JNJ)
10/21
UNITED RENTALS, INC.
(URI)
10/21
INTUITIVE SURGICAL INC
(ISRG)
10/20
CLEVELAND-CLIFFS INC.
(CLF)
10/20
General Motors Co
(GM)
10/20
RTX Corp
(RTX)
10/20
GENERAL ELECTRIC CO
(GE)
10/20
PEGASYSTEMS INC
(PEGA)
10/20
Albertsons Companies, Inc.
(ACI)
10/20
3M CO
(MMM)
10/20
FACTSET RESEARCH SYSTEMS INC
(FDS)
10/20
GENUINE PARTS CO
(GPC)
10/20
MSCI Inc.
(MSCI)
10/20
EQUIFAX INC
(EFX)
10/19
FASTENAL CO
(FAST)
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/21
NETFLIX INC
(NFLX)
10/21
AT&T INC.
(T)
10/21
CSX CORP
(CSX)
10/21
United Airlines Holdings, Inc.
(UAL)
10/21
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
(WAB)
10/21
Elevance Health, Inc.
(ELV)
10/21
JOHNSON & JOHNSON
(JNJ)
10/21
UNITED RENTALS, INC.
(URI)
10/21
INTUITIVE SURGICAL INC
(ISRG)
10/20
CLEVELAND-CLIFFS INC.
(CLF)
10/20
General Motors Co
(GM)
10/20
RTX Corp
(RTX)
10/20
GENERAL ELECTRIC CO
(GE)
10/20
PEGASYSTEMS INC
(PEGA)
10/20
Albertsons Companies, Inc.
(ACI)
10/20
3M CO
(MMM)
10/20
FACTSET RESEARCH SYSTEMS INC
(FDS)
10/20
GENUINE PARTS CO
(GPC)
10/20
MSCI Inc.
(MSCI)
10/20
EQUIFAX INC
(EFX)
10/19
FASTENAL CO
(FAST)
10/16
Accenture plc
(ACN)
10/16
TRAVELERS COMPANIES, INC.
(TRV)
10/15
MARSH & MCLENNAN COMPANIES, INC.
(MRSH)
10/13
DOMINOS PIZZA INC
(DPZ)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$25,399M
Net Income
$210M
Net Profit Margin
0.83%
EPS
$0.09
Unit: Million (M) dollars
Revenue Breakdown
Innovative Medicine
Med Tech
Revenue Breakdown
US
Europe
Asia Pacific Africa
Western Hemisphere Excluding US
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-09-27
2026-06-28
2026-03-29
2025-12-28
Sales to customers (note 9)
25,399
25,310
24,062
24,564
Cost of products sold
8,097
8,051
8,106
7,968
Gross profit
17,302
17,259
15,956
16,596
Selling, marketing and administrative expenses
6,285
6,432
6,034
6,753
Research and development expense
4,652
3,653
3,527
4,252
In-process research and development impairments
339
-
36
81
Interest income
186
219
229
237
Interest expense, net of portion capitalized
217
281
272
214
Other (income) expense, net
-5,780
-331
-294
-483
Restructuring (note 12)
181
34
32
84
Earnings before provision for taxes on income
34
6,747
5,990
4,966
(benefit from)/provision for taxes on income (note5)
-176
1,213
755
-150
Net earnings from continuing operations
-
-
-
5,116*
Net earnings from discontinued operations
-
-
-
0*
Net earnings
210
5,534
5,235
5,116
Basic EPS
0.09
2.3
2.17
2.125
Diluted EPS
0.09
2.27
2.14
2.091
Basic Average Shares
2,409,600,000
2,407,400,000
2,408,700,000
2,407,800,000
Diluted Average Shares
2,448,600,000
2,440,100,000
2,445,200,000
2,446,100,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
JNJ Income Statement Sankey Diagram
Sankey diagram visualizing JNJ income statement for the period
Innovative Medicine
$16,757M
(7.67%↑ Y/Y)
Med Tech
$8,642M
(2.51%↑ Y/Y)
Sales to customers
(note 9)
$25,399M
(5.86%↑ Y/Y)
Gross profit
$17,302M
(3.67%↑ Y/Y)
Interest income
$186M
(-18.06%↓ Y/Y)
Cost of products sold
$8,097M
(10.87%↑ Y/Y)
(benefit
from)/provision for taxes on...
-$176M
(-107.52%↓ Y/Y)
Earnings before
provision for taxes on...
$34M
(-99.55%↓ Y/Y)
Selling, marketing and
administrative expenses
$6,285M
(6.13%↑ Y/Y)
Other (income)
expense, net
-$5,780M
(-1309.21%↓ Y/Y)
Research and development
expense
$4,652M
(26.69%↑ Y/Y)
In-process research and
development impairments
$339M
Interest expense, net of
portion capitalized
$217M
(-11.43%↓ Y/Y)
Restructuring (note 12)
$181M
(187.30%↑ Y/Y)
Net earnings
$210M
(-95.92%↓ Y/Y)
Buy us a coffee
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
JNJ_BIG_BIG copy-svg
JOHNSON & JOHNSON (JNJ)
Show more